Table 4.
Frequency distribution of patients, stratified by detectability of serum epinephrine and vasoactive drug administered
Serum epinephrine | Total | p-value* | OR (95% CI) | ||
---|---|---|---|---|---|
Undetectable | Detectable | ||||
Patients receiving epinephrine, n (%) | |||||
No | 60 (67.7) | 22 (24.4) | 82 (91.1) | < 0.01 | - |
Yes | 0 (0.0) | 8 (8.9) | 8 (8.9) | - | |
Total | 60 (66.7) | 30 (33.3) | 90 (100.0) | ||
Patients receiving vasopressin, norepinephrine, or both, n (%) | |||||
No | 24 (29.3) | 12 (14.6) | 36 (43.9) | 0.31 | 1.00 (Reference) |
Yes | 36 (43.9) | 10 (12.2) | 46 (56.1) | 0.55 (0.21; 1.49) | |
Total | 60 (73.2) | 22 (26.8) | 82 (100.0) |
OR odds ratio; 95% CI 95% confidence interval
*Fisher’s exact test